Skip to content
Case report Open access

Clinicopathological analysis of breast cancer-related paraneoplastic syndrome: a case series of 6 patients

Jul 2026 · Translational Breast Cancer Research · Vol 7 · 0 citations · 22 references
Medicine

Abstract

Background Breast cancer-related paraneoplastic syndrome (PNS) is rare, with an estimated incidence of approximately 0.3%. Neurological symptoms often precede the diagnosis of breast cancer; however, the clinicopathological characteristics, antibody profiles, and treatment outcomes remain incompletely defined, particularly in Asian populations. This case series from a large Chinese tertiary center aims to describe these features and highlight diagnostic challenges. Case Description Six female patients with histopathologically confirmed invasive ductal carcinoma (median age 63 years, range 53–68 years) were included. Neurological symptoms preceded breast cancer diagnosis in 4/6 patients (mean interval 3–4 months) and occurred after prior breast cancer surgery in 2/6 patients (intervals of 4 and 5 years). Phenotypes included paraneoplastic cerebellar degeneration (PCD) (2/6), brainstem encephalitis (1/6), limbic encephalitis (LE) (1/6) and mixed sensorimotor/extrapyramidal syndrome (2/6). Antibody testing revealed anti-Yo positivity in 3/6 patients, anti-Ri positivity in 2/6, and one patient had combined anti-Ri, amphiphysin, and PNMA2 antibodies; one patient tested negative. All patients underwent complete resection (R0) and received systemic oncologic therapy. After a median follow-up of 44 months, neurological outcomes were partial remission (PR) (2/6), stable disease (SD) (2/6), and progressive disease (PD) (2/6). The 5-year overall survival (OS) rate was 83.3% (one non-cancer death). Conclusions Neurological symptoms in patients with breast cancer-related PNS frequently precede the cancer diagnosis. Anti-Yo and anti-Ri antibodies were the most detected types in this study. R0 resection combined with systemic therapy was associated with stabilization or improvement of neurological symptoms in some patients.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.